New study reveals how vancomycin delivery method impacts kidney health
NCT ID NCT05823116
First seen Jan 05, 2026 · Last updated Apr 28, 2026 · Updated 17 times
Summary
This study looked at 37 hospitalized adults who needed the antibiotic vancomycin. Participants were randomly assigned to receive the drug as a continuous drip or as intermittent doses. Researchers measured kidney function and injury markers to see if one method is safer for the kidneys.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VANCOMYCIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Kentucky
Lexington, Kentucky, 40506, United States
Conditions
Explore the condition pages connected to this study.